Stay updated on Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial
Sign up to get notified when there's something new on the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page.

Latest updates to the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page
- Check7 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check14 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check36 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check65 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check72 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference2%
Stay in the know with updates to Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Peanut Allergy Study with Dupilumab as Adjunct Clinical Trial page.